Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Telehealth Language Intervention for Children With Autism Ages 2-4 Years

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04675580
Recruitment Status : Recruiting
First Posted : December 19, 2020
Last Update Posted : December 30, 2020
Sponsor:
Collaborator:
Simons Foundation
Information provided by (Responsible Party):
Weill Medical College of Cornell University

Brief Summary:
The main goal of this intervention is to increase caregivers' use of interactive play and communication strategies to improve the child's early sentence development using telemedicine and video-based feedback.

Condition or disease Intervention/treatment Phase
Autism Spectrum Disorder Behavioral: Toy Talk Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 18 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial
Actual Study Start Date : December 23, 2020
Estimated Primary Completion Date : August 1, 2021
Estimated Study Completion Date : August 1, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Caregivers

Arm Intervention/treatment
Experimental: Tele Toy Talk
Caregivers of child participants receive 1-hour of telemedicine featuring parent-mediated naturalistic developmental behavioral intervention weekly for 8 weeks, with additional 1-hour booster sessions at 10 weeks and 12 weeks.
Behavioral: Toy Talk
Language modeling strategy encouraging caregivers to (1) talk about the toys the child is playing with, including the states, actions, and properties of the toys and (2) give the object its name using a lexical noun phrase.

No Intervention: Multiple Baseline
Prior to receiving the intervention, participants will be randomized into one of three baseline conditions: a three-, four-, or five-week baseline period. At each weekly baseline session, caregivers will record the Tele-BOSCC (see Outcomes Measures section).



Primary Outcome Measures :
  1. Change in number of unique combinations of subjects and verbs - caregiver [ Time Frame: Baseline (Before starting intervention); Week 4; Week 8; Week 12 ]
    Number of unique combinations of subjects and verbs used by the caregiver at baseline, intervention midpoint, and post-evaluation. This will be calculated by transcribing 12-minute language samples from the BOSCC using Systematic Analysis of Language Transcripts (SALT) software.

  2. Change in number of unique combinations of subjects and verbs - child [ Time Frame: Baseline (Before starting intervention); Week 4; Week 8; Week 12 ]
    Number of unique combinations of subjects and verbs used by the child at baseline, intervention midpoint, and post-evaluation. This will be calculated by transcribing 12-minute language samples from the BOSCC using Systematic Analysis of Language Transcripts (SALT) software.

  3. Change in caregiver mean length of utterance [ Time Frame: Baseline (before starting intervention); Week 4; Week 8; Week 12 ]
    Mean length of utterance used by caregiver at baseline, intervention midpoint, and post-evaluation. This will be calculated by transcribing 12-minute language samples from the BOSCC using Systematic Analysis of Language Transcripts (SALT) software.

  4. Change in child mean length of utterance [ Time Frame: Baseline (before starting intervention); Week 4; Week 8; Week 12 ]
    Mean length of utterance used by child at baseline, intervention midpoint, and post-evaluation. This will be calculated by transcribing 12-minute language samples from the BOSCC using Systematic Analysis of Language Transcripts (SALT) software.

  5. Change in Brief Observation of Social Communication Change (BOSCC) scores [ Time Frame: Baseline (before starting intervention); Week 4; Week 8; Week 12 ]
    Child's scores on the Brief Observation of Social Communication Change (BOSCC) at baseline, intervention midpoint, and post-evaluation. BOSCC scores are not linear. Each item is rated on a 6-point scale from 0 (abnormality is not present) to 5 (abnormality is present and significantly impairs functioning).


Secondary Outcome Measures :
  1. Change in scores on the Parent Motivation Inventory (PMI) [ Time Frame: Baseline (before starting intervention); Week 8; Week 12 ]
    Caregiver scores on the Parent Motivation Inventory (PMI) at baseline, intervention midpoint, and post-evaluation. The PMI is a 25-item self-report measure of parent treatment motivation on a five-point Likert-type scale (1=strongly disagree; 5=strongly agree).

  2. Change in scores on the Observation of Spontaneous Expressive Language (OSEL) - baseline [ Time Frame: Baseline (before starting intervention); Week 12 ]
    Child's scores on the Observation of Spontaneous Expressive Language at baseline and post-evaluation. Scores on the OSEL are not linear. Scores range from 0 to 3, with higher scores indicating more impairment.

  3. Change in scores on the Vineland-3 [ Time Frame: Baseline (before starting intervention); Week 8; Week 12 ]
    Scores on the Vineland-3 at baseline, intervention midpoint, and post-evaluation. The Vineland-3 provides norm-referenced scaled scores for 11 skill areas (M = 10; SD = 3) as well as standard scores (M =100, SD = 15) for three adaptive domains.


Other Outcome Measures:
  1. Change in scores on the Acceptance and Action Questionnaire, Second Version (AAQ-II) [ Time Frame: Baseline (before starting intervention); Week 8; Week 12 ]
    Caregiver scores on the Acceptance and Action Questionnaire, Second Version (AAQ-II) at baseline, intervention midpoint, and post-evaluation. Items are rated on a Likert-type scale of 1 through 7, and scores range from 7 to 49.

  2. Change in scores on the Emotion Regulation Questionnaire (ERQ) [ Time Frame: Baseline (before starting intervention); Week 8; Week 12 ]
    Caregiver scores on the Emotion Regulation Questionnaire (ERQ) at baseline, intervention midpoint, and post-evaluation. The ERQ is a 10-item scale with each item consisting of a 7-point Likert-type scale ranging from 1 to 7.

  3. Change in scores on the Caregiver Strain Questionnaire - Short Form 7 (CSQ-SF 7) [ Time Frame: Baseline (before starting intervention); Week 8; Week 12 ]
    Scores on the Caregiver Strain Questionnaire - Short Form 7 (CSQ-SF 7) at baseline, intervention midpoint, and post-evaluation. The CSQ-SF7 contains seven items, with response options on a five-point Likert-type scale.

  4. Change in scores on the Parent Stress Index-4th Edition (PSI-4) [ Time Frame: Baseline (before starting intervention); Week 8; Week 12 ]
    Scores on the Parent Stress Index (PSI-4) at baseline, intervention midpoint, and post-evaluation. The PSI-4 is a 120-item inventory that provides two domain scores that are quantified using T scores (mean of 50; standard deviation of 10).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   2 Years to 4 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of autism spectrum disorder (ASD) and/or communication disorder
  • Child speaks at least 50 single words or uses emerging word combinations
  • Caregivers have Internet availability from their home

Exclusion Criteria:

  • Child speaks using complex sentences
  • Child is not within 2 to 4 years of age at time of enrollment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04675580


Contacts
Layout table for location contacts
Contact: Elizabeth P McKernan, Ph.D. 9149975832 ext 9149975832 epm4001@med.cornell.edu

Locations
Layout table for location information
United States, New York
Center for Autism and the Developing Brain/New York-Presbyterian Hospital Recruiting
White Plains, New York, United States, 10605
Contact: Marcella Sanchez    914-997-5575    mab9254@med.cornell.edu   
Sponsors and Collaborators
Weill Medical College of Cornell University
Simons Foundation
Investigators
Layout table for investigator information
Principal Investigator: So Hyun Kim, Ph.D. Weill Cornell Medicine
Layout table for additonal information
Responsible Party: Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT04675580    
Other Study ID Numbers: 19-07020518
First Posted: December 19, 2020    Key Record Dates
Last Update Posted: December 30, 2020
Last Verified: December 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders